Recent Publications (2017 - 2021)

2021

1. Yoo J, Grewal P, Hotelling J, Papamanoli A, Cao K, Dhaliwal S, Jacob R, Mojahedi A, Bloom ME, Marcos LA, Skopicki HA, Kalogeropoulos AP. Admission NT-proBNP and outcomes in patients without history of heart failure hospitalized with COVID-19. ESC Heart Fail. 2021

2. Naidu SS, Baron SJ, Eng MH, Sathanandam SK, Zidar DA, Feldman DN, Ing FF, Latif F, Lim MJ, Henry TD, Rao SV, Dangas GD, Hermiller JB, Daggubati R, Shah B, Ang L, Aronow HD, Banerjee S, Box LC, Caputo RP, Cohen MG, Coylewright M, Duffy PL, Goldsweig AM, Hagler DJ, Hawkins BM, Hijazi ZM, Jayasuriya S, Justino H, Klein AJ, Kliger C, Li J, Mahmud E, Messenger JC, Morray BH, Parikh SA, Reilly J, Secemsky E, Shishehbor MH, Szerlip M, Yakubov SJ, Grines CL, Alvarez-Breckenridge J, Baird C, Baker D, Berry C, Bhattacharya M, Bilazarian S, Bowen R, Brounstein K, Cameron C, Cavalcante R, Culbertson C, Diaz P, Emanuele S, Evans E, Fletcher R, Fortune T, Gaiha P, Govender D, Gutfinger D, Haggstrom K, Herzog A, Hite D, Kalich B, Kirkland A, Kohler T, Laurisden H, Livolsi K, Lombardi L, Lowe S, Marhenke K, Meikle J, Moat N, Mueller M, Patarca R, Popma J, Rangwala N, Simonton C, Stokes J, Taber M, Tieche C, Venditto J, West NEJ, Zinn L. Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions (SCAI) 2021 think tank. Catheter Cardiovasc Interv. 2021

3. Patel JK, Schoenfeld E, Hou W, Singer A, Rakowski E, Ahmad S, Patel R, Parikh PB, Smaldone G. Inhaled nitric oxide in adults with in-hospital cardiac arrest: A feasibility study. Nitric Oxide. 2021;115:30-33.

4. Parikh PB, Weber-Fishkin S, George S, Kane J, Pyo R. Balloon Aortic Valvuloplasty With Same-Setting Complex Percutaneous Coronary Intervention in the TAVR Era: A Case Series. J Invasive Cardiol. 2021;33:E479-E482.

5. Kalogeropoulos AP, Hall ME. Insights From MESA (Multi-Ethnic Study of Atherosclerosis): Into the Crypts of Fat. J Am Coll Cardiol. 2021;77:2653-2655.

6. Sheikh M, Ahmed N, Gandhi H, Chen O. Report of ventricular fibrillation in a 44-year-old man using kratom. BMJ Case Rep. 2021;14:e237837.

7. Waksman R, Torguson R, Medranda GA, Shea C, Zhang C, Gordon P, Ehsan A, Wilson SR, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Buchbinder M, Asch F, Weissman G, Ben-Dor I, Shults C, Garcia-Garcia HM, Satler LF, Rogers T. Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial. Am Heart J. 2021;237:25-33.

8. Goulbourne CA, Sharma N, Cecchini MJ, Bloom M, Singh A, Skopicki H, Pyo R. Giant Cell, Giant Problems: A Case of Giant Cell Myocarditis Complicated by Cardiogenic Shock and Refractory Ventricular Tachycardia Managed With a Mechanical Circulatory Support Device. Cardiovasc Revasc Med. 2021;28S:180-185.

9. Koufou EE, Arfaras-Melainis A, Rawal S, Kalogeropoulos AP. Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence. J Clin Med. 2021;10:E203.

10. Patel JK, Sinha N, Hou W, Shah R, Qadeer A, Tran L, Parikh PB, Parnia S. Association of post-resuscitation inflammatory response with favorable neurologic outcomes in adults with in-hospital cardiac arrest. Resuscitation. 2021;159:54-59.

11. Papamanoli A, Yoo J, Grewal P, Predun W, Hotelling J, Jacob R, Mojahedi A, Skopicki HA, Mansour M, Marcos LA, Kalogeropoulos AP. High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia. Eur J Clin Invest. 2021;51:e13458.

12. Khan JM, Rogers T, Weissman G, Torguson R, Rodriguez-Weisson FJ, Chezar-Azerrad C, Greenspun B, Gupta N, Medvedofsky D, Zhang C, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Shults C, Buchbinder M, Garcia-Garcia HM, Kolm P, Satler LF, Hashim H, Ben-Dor I, Asch FM, Waksman R. Anatomical Characteristics Associated With Hypoattenuated Leaflet Thickening in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2021;27:1-6.

2020

13. Akinyele B, Marine JE, Love C, Crawford TC, Chrispin J, Vlay SC, Spragg DD, Eagle KA, Berger RD, Calkins H, Tomaselli GF, Sinha SK. Unregulated online sales of cardiac implantable electronic devices in the United States: A six-month assessment. Heart Rhythm O2. 2020;1:235-238.

14. Balgobin CA, Zhang X, Lima FV, Avila C, Parikh PB, Yang J, Stergiopoulos K. Risk Factors and Timing of Acute Myocardial Infarction Associated With Pregnancy: Insights From the National Inpatient Sample. J Am Heart Assoc. 2020;9:e016623.

15. Kott J, Reichek N, Butler J, Arbeit L, Mallipattu SK. Cardiac Imaging in Dialysis Patients. Kidney Med. 2020;2:629-638.

16. Kalogeropoulos AP, Simitsis P, Skopicki HA. Secrets of spironolactone: continuing insights from TOPCAT Americas. Eur J Heart Fail. 2020;22:1625-1627.

17. Hamid A, Vaduganathan M, Oshunbade AA, Ayyalasomayajula KK, Kalogeropoulos AP, Lien LF, Shafi T, Hall ME, Butler J. Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center. J Cardiovasc Pharmacol. 2020;76:313-320.

18. Kalogeropoulos AP, Thankachen J, Butler J, Fang JC. Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis. Eur J Heart Fail. 2020;22:1600-1610.

19. Waksman R, Craig PE, Torguson R, Asch FM, Weissman G, Ruiz D, Gordon P, Ehsan A, Parikh P, Bilfinger T, Levitt R, Hahn C, Roberts D, Ingram M, Hanna N, Comas G, Zhang C, Ben-Dor I, Satler LF, Garcia-Garcia HM, Shults C, Rogers T. Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis. JACC Cardiovasc Interv. 2020;13:1019-1027.

20. Arvanitaki A, Michou E, Kalogeropoulos A, Karvounis H, Giannakoulas G. Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations. ESC Heart Fail. 2020;7:1477-1487.

21. Kokkinidis DG, Zareifopoulos N, Theochari CA, Arfaras-Melainis A, Papanastasiou CA, Uppal D, Giannakoulas G, Kalogeropoulos AP, Fontes JDT. Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis. Stroke. 2020;51:1662-1666.

22. Savvoulidis P, Kalogeropoulos AP, Raptis V, Rafailidis V, Georgianos PI, Balaskas EV, Kouskouras K, Karvounis H, Hadjimiltiades S. Calcification of coronary arteries and aortic valve and circulating a-klotho levels in patients with chronic kidney disease. J Thorac Dis. 2020;12:431-437.

23. Rogers T, Greenspun BC, Weissman G, Torguson R, Craig P, Shults C, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Buchbinder M, Asch F, Garcia-Garcia HM, Okubagzi P, Ben-Dor I, Satler LF, Waksman R. Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. JACC Cardiovasc Interv. 2020;13:726-735.

24. Bhasin V, Mehta A, Skopicki HA, Parikh PB. Predictors of Aspirin Nonadherence in Adults With Prior Myocardial Infarction. Crit Pathw Cardiol. 2020;19:115-118.

25. Ozaki Y, Garcia-Garcia HM, Rogers T, Torguson R, Craig PE, Hideo-Kajita A, Gordon P, Ehsan A, Parikh P, Bilfinger T, Butzel D, Buchanan S, Levitt R, Hahn C, Buchbinder M, Hanna N, Garrett R, Wilson SR, Goncalves JA, Ali S, Asch FM, Weissman G, Shults C, Ben-Dor I, Satler LF, Waksman R. Coronary Artery Disease Assessed by Computed Tomography-Based Leaman Score in Patients With Low-Risk Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020;125:1216-1221.

26. Olgin JE, Lee BK, Vittinghoff E, Morin DP, Zweibel S, Rashba E, Chung EH, Borggrefe M, Hulley S, Lin F, Hue TF, Pletcher MJ. Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses. J Cardiovasc Electrophysiol. 2020;31:1009-1018.

27. Bianchi M, Marom G, Ghosh RP, Rotman OM, Parikh P, Gruberg L, Bluestein D. Correction to: Patient-specific simulation of transcatheter aortic valve replacement: impact of deployment options on paravalvular leakage. Biomech Model Mechanobiol. 2020;19:779.

28. Saraf A, De Staercke C, Everitt I, Haouzi A, Ko YA, Jennings S, Kim JH, Rodriguez FH, Kalogeropoulos AP, Quyyumi A, Book W. Biomarker profile in stable Fontan patients. Int J Cardiol. 2020;305:56-62.

29. Kalogeropoulos A, Papadimitriou L, Georgiopoulou VV, Dunbar SB, Skopicki H, Butler J. Low- Versus Moderate-Sodium Diet in Patients With Recent Hospitalization for Heart Failure: The PROHIBIT (Prevent Adverse Outcomes in Heart Failure by Limiting Sodium) Pilot Study. Circ Heart Fail. 2020;13:e006389.

30. Gracia E, Wang TY, Callahan S, Bilfinger T, Tannous H, Pyo R, Kort S, Skopicki H, Weinstein J, Patel N, Montellese D, Korlipara G, Khan S, Chikwe J, Parikh PB. Impact of Severity of Chronic Kidney Disease on Management and Outcomes Following Transcatheter Aortic Valve Replacement with Newer-Generation Transcatheter Valves. J Invasive Cardiol. 2020;32:25-29.

31. Butler J, Greene SJ, Shah SH, Shah SJ, Anstrom KJ, Kim RJ, Kalogeropoulos AP, Velazquez EJ, Hernandez AF, Desvigne-Nickens P, Scherzer R, Hsue PY, Braunwald E. Diastolic Dysfunction in Patients with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results from the CHART Study. J Card Fail. 2020;26:371-380.

32. Khan MS, Kalogeropoulos AP, Butler J. Variation in Placebo Effect on Health-Related Quality of Life in Heart Failure (from the TOPCAT Trial). Am J Cardiol. 2020;125:82-86.

33. Marcos LA, Castle PM, Smith K, Khoo T, Morley EJ, Bloom M, Fries BC. Risk factors for Lyme carditis: A case-control study. Eur J Prev Cardiol. 2020;27:2200-2204.

2019

34. Khan JM, Rogers T, Waksman R, Torguson R, Weissman G, Medvedofsky D, Craig PE, Zhang C, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Shults C, Garcia-Garcia HM, Kolm P, Satler LF, Buchbinder M, Ben-Dor I, Asch FM. Hemodynamics and Subclinical Leaflet Thrombosis in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement. Circ Cardiovasc Imaging. 2019;12:e009608.

35. Kalogeropoulos AP, Skopicki H. Cognitive Decline in Heart Failure: The Silent Enemy. JACC Heart Fail. 2019;7:1054-1055.

36. Patel JK, Meng H, Qadeer A, Parikh PB. Impact of Extracorporeal Membrane Oxygenation on Mortality in Adults with Cardiac Arrest. Am J Cardiol. 2019;124:1857-1861.

37. Manjur JE, Ciuffo MM, Burdowski J, George S, Kalogeropoulos A, Chen O. Scombroid Fish Poisoning Leading to Vasospastic Angina: A Rare Etiology of Chest Pain. JACC Case Rep. 2019;1:322-326.

38. Kalogeropoulos AP, Goulbourne C, Butler J. Diagnosis and Prevention of Hypertensive Heart Failure. Heart Fail Clin. 2019;15:435-445.

39. Kalogeropoulos AP, Papanastasiou CA. Egg consumption: to eat or not to eat. J Thorac Dis. 2019;11:2185-2187.

40. Greene SJ, Felker GM, Giczewska A, Kalogeropoulos AP, Ambrosy AP, Chakraborty H, DeVore AD, Fudim M, McNulty SE, Mentz RJ, Vaduganathan M, Hernandez AF, Butler J. Spironolactone in Acute Heart Failure Patients with Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial. Can J Cardiol. 2019;35:1097-1105.

41. Gerardin J, Raskind-Hood C, Rodriguez FH, Hoffman T, Kalogeropoulos A, Hogue C, Book W. Lost in the system? Transfer to adult congenital heart disease care-Challenges and solutions. Congenit Heart Dis. 2019;14:541-548.

42. Waksman R, Corso PJ, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Buchbinder M, Asch F, Weissman G, Ben-Dor I, Shults C, Bastian R, Craig PE, Ali S, Garcia-Garcia HM, Kolm P, Zou Q, Satler LF, Rogers T. TAVR in Low-Risk Patients: 1-Year Results From the LRT Trial. JACC Cardiovasc Interv. 2019;12:901-907.

43. Kalogeropoulos AP, Butler J. The other serelaxin in acute heart failure study: lessons from a pragmatic clinical trial. Eur J Heart Fail. 2019;21:334-336.

44. Savvoulidis P, Butler J, Kalogeropoulos A. Cardiomyopathy and Heart Failure in Patients With HIV Infection. Can J Cardiol. 2019;35:299-309.

45. Bianchi M, Marom G, Ghosh RP, Rotman OM, Parikh P, Gruberg L, Bluestein D. Patient-specific simulation of transcatheter aortic valve replacement: impact of deployment options on paravalvular leakage. Biomech Model Mechanobiol. 2019;18:435-451.

46. Marine JE, Crawford TC, Sinha SK, Pavri BB, Sundaram S, Eagle KA, Vlay SC, Deering TF. Global disparities in cardiac pacemaker therapy: Problem statement, potential solution, and call to action. Heart Rhythm. 2019;16:153-155.

2018

47. Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK, VEST I. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med. 2018;379:1205-1215.

48. Sinha SK, Sivasambu B, Yenokyan G, Crawford TC, Chrispin J, Eagle KA, Barth AS, Rickard JJ, Spragg DD, Vlay SC, Berger R, Love C, Calkins H, Tomaselli GF, Marine JE. Worldwide pacemaker and defibrillator reuse: Systematic review and meta-analysis of contemporary trials. Pacing Clin Electrophysiol. 2018;41:1500-1507.

49. Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Asch F, Weissman G, Ben-Dor I, Shults C, Bastian R, Craig PE, Garcia-Garcia HM, Kolm P, Zou Q, Satler LF, Corso PJ. Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis. J Am Coll Cardiol. 2018;72:2095-2105.

50. Hedley JS, Samman-Tahhan A, McCue AA, Bjork JB, Butler J, Georgiopoulou VV, Morris AA, Kalogeropoulos AP. Definitions of Stage D heart failure and outcomes among outpatients with heart failure and reduced ejection fraction. Int J Cardiol. 2018;272:250-254.

51. Samman-Tahhan A, Hedley JS, McCue AA, Bjork JB, Georgiopoulou VV, Morris AA, Butler J, Kalogeropoulos AP. INTERMACS Profiles and Outcomes Among Non-Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction. JACC Heart Fail. 2018;6:743-753.

52. Schecter S, Lin W, Gopal A, Fan R, Rashba E. Haptics and the heart: Force and tactile feedback system for cardiovascular interventions. Cardiovasc Revasc Med. 2018;19:36-40.

53. Lima FV, Singh S, Parikh PB, Gruberg L. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Revasc Med. 2018;19:16-20.

54. Srivastava P, Butler J, Shroyer AL, Lacey M, Parikh PB. Impact of Depressive Disorder on Access and Quality of Care in Veterans with Prevalent Cardiovascular Disease. Am J Cardiol. 2018;121:1629-1633.

55. Georgiopoulou VV, Velayati A, Burkman G, Li S, Farooq K, Samman-Tahhan A, Papadimitriou L, Butler J, Kalogeropoulos AP. Comorbidities, Sociodemographic Factors, and Hospitalizations in Outpatients with Heart Failure and Preserved Ejection Fraction. Am J Cardiol. 2018;121:1207-1213.

2017

56. Reichek N. Myocardial Strain: Still a Long Way to Go. Circ Cardiovasc Imaging. 2017;10:e007145.

57. Kalogeropoulos AP, Butler J. Heart rate in heart failure with preserved ejection fraction: target or marker. Eur J Heart Fail. 2017;19:1504-1506.

58. Bloom MW, Greenberg B, Jaarsma T, Januzzi JL, Lam CSP, Maggioni AP, Trochu JN, Butler J. Heart failure with reduced ejection fraction. Nat Rev Dis Primers. 2017;3:17058.

59. Goyfman M, Kort S. Echocardiographic evaluation of patients presenting with acutely decompensated heart failure in the setting of dietary or medication noncompliance-Is there a role. Echocardiography. 2017;34:1426-1431.

60. Patel JK, Meng H, Parikh PB. Trends in Management and Mortality in Adults Hospitalized With Cardiac Arrest in the United States. J Intensive Care Med. 2019;34:252-258.

61. Miller C, Karimi R, Silbernagel S, Kostrubiak D, Schiavone F, Zhang Q, Yang J, Rashba E, Meliker JR. Mercury, omega-3 fatty acids, and seafood intake are not associated with heart rate variability or QT interval. Arch Environ Occup Health. 2018;73:251-257.

62. Cohen R, Bavishi C, Haider S, Thankachen J, Rozanski A. Meta-Analysis of Relation of Vital Exhaustion to Cardiovascular Disease Events. Am J Cardiol. 2017;119:1211-1216.

63. Hammadah M, Kalogeropoulos AP, Georgiopoulou VV, Weber M, Wu Y, Hazen SL, Butler J, Tang WHW. High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure. Eur J Heart Fail. 2017;19:748-755.

64. Lee MS, Shlofmitz E, Haag E, Santiago L, Pollack S, Reichek N, Shlofmitz RA. Optimal Same-Day Platelet Inhibition in Patients Receiving Drug-Eluting Stents With or Without Previous Maintenance Thienopyridine Therapy: from the Evaluation of Platelet Inhibition in Patients Having A VerifyNow Assay (EPIPHANY) Trial. Am J Cardiol. 2017;119:991-995.

65. Kalogeropoulos AP, Butler J. Left Ventricular Ejection Fraction in Patients With Acute Heart Failure: A Limited Tool. Rev Esp Cardiol (Engl Ed). 2017;70:318-319.

66. Vaduganathan M, Samman-Tahhan A, Patel RB, Kelkar A, Papadimitriou L, Georgiopoulou VV, Greene SJ, Kalogeropoulos AP, Peterson E, Fonarow GC, Gheorghiade M, Butler J. Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review. Int J Cardiol. 2017;230:301-303.

67. Sharma N, Lee J, Aponte CS, Marmur JD, Lawson WE, Mann NN, Salifu MO, Youssef I, McFarlane SI. Clinical Characteristics and Angiographic Findings of Acute Myocardial Infarction Associated With Marijuana Use: Consecutive Case Series. Scifed J Cardiol. 2017;2:1000011.

68. Lee J, Sharma N, Aponte CS, Zaidi S, Fung D, Marmur JD, Salifu M, Myers A, Lawson WE, Mann NN, McFarlane SI. Clinical Characteristics and Angiographic Findings of Myocardial Infarction among Marijuana Users and Non-Users. Scifed J Cardiol. 2017;1:1000008.

69. Butler J, Epstein SE, Greene SJ, Quyyumi AA, Sikora S, Kim RJ, Anderson AS, Wilcox JE, Tankovich NI, Lipinski MJ, Ko YA, Margulies KB, Cole RT, Skopicki HA, Gheorghiade M. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. Circ Res. 2017;120:332-340.

70. Georgiopoulou VV, Kalogeropoulos AP, Chowdhury R, Binongo JN, Bibbins-Domingo K, Rodondi N, Simonsick EM, Harris T, Newman AB, Kritchevsky SB, Butler J, Health ABCS. Exercise Capacity, Heart Failure Risk, and Mortality in Older Adults: The Health ABC Study. Am J Prev Med. 2017;52:144-153.